What is the appropriate vancomycin dosing regimen for an 81‑lb (approximately 37 kg) patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vancomycin Dosing for 81 lb (37 kg) Patient

For this 37 kg patient, administer vancomycin 15-20 mg/kg every 8-12 hours (approximately 555-740 mg every 8-12 hours), with each dose infused over at least 60 minutes, targeting trough concentrations of 10-20 mg/L depending on infection severity.

Weight-Based Dosing Algorithm

The IDSA/ASHP/SIDP consensus guidelines establish that vancomycin dosing must be based on actual body weight 1. For your 37 kg patient:

  • Standard dosing: 15-20 mg/kg every 8-12 hours
  • Calculated dose range: 555 mg (15 mg/kg × 37 kg) to 740 mg (20 mg/kg × 37 kg)
  • Practical dosing: Round to 500-750 mg every 8-12 hours based on infection severity

The FDA label confirms pediatric dosing at 10 mg/kg every 6 hours, but adult guidelines supersede this for patients requiring higher intensity therapy 2.

Target Trough Concentrations

Your target trough depends on infection type 1:

  • For complicated infections (bacteremia, endocarditis, osteomyelitis, meningitis, hospital-acquired pneumonia): Target trough 15-20 mg/L
  • For less severe infections: Target trough 10-15 mg/L
  • Minimum for all patients: Maintain trough ≥10 mg/L to prevent resistance development

Infusion Requirements

Critical safety consideration: Each dose must be infused over at least 60 minutes, or at a rate ≤10 mg/min, whichever is longer 2. For doses >1 g, extend infusion to 1.5-2 hours 1. This prevents infusion-related reactions including "red man syndrome."

Therapeutic Drug Monitoring

  • First trough level: Draw just before the 4th dose (at steady state) 1
  • Frequency: For prolonged therapy or high-intensity dosing (targeting 15-20 mg/L), monitor troughs regularly 1
  • Short courses (≤5 days) or lower-intensity dosing may not require frequent monitoring 1

Renal Function Considerations

Essential: Assess renal function before dosing. If creatinine clearance is reduced:

  • Use the FDA dosing table for renal impairment 2
  • Initial dose should still be ≥15 mg/kg even with mild-moderate renal insufficiency
  • Extend dosing intervals rather than reducing individual doses
  • Monitor trough levels more frequently with unstable renal function 1

Common Pitfalls to Avoid

  1. Underdosing: Standard "500 mg every 6 hours" or "1 g every 12 hours" regimens ignore patient-specific factors and often fail to achieve target AUC/MIC ratios 1

  2. Delayed monitoring: Waiting beyond the 4th dose to check levels risks prolonged subtherapeutic or toxic exposure

  3. Ignoring MIC: If the organism's MIC is ≥2 mg/L, conventional dosing cannot achieve target AUC/MIC of ≥400, and alternative therapy should be considered 1

  4. Rapid infusion: Infusing too quickly significantly increases risk of infusion reactions 2

Nephrotoxicity Monitoring

Define nephrotoxicity as ≥2-3 consecutive serum creatinine increases of ≥0.5 mg/dL or ≥50% from baseline after several days of therapy, absent other causes 1. Monitor more closely if:

  • Targeting aggressive troughs (15-20 mg/L)
  • Concurrent nephrotoxic agents
  • Unstable renal function

Peak level monitoring is not recommended for nephrotoxicity prevention 1.

Practical Starting Regimen for 37 kg Patient

For serious infections (bacteremia, pneumonia, osteomyelitis):

  • 750 mg IV every 12 hours (20 mg/kg)
  • Infuse over 90 minutes
  • Check trough before 4th dose
  • Target trough 15-20 mg/L

For moderate infections:

  • 500-600 mg IV every 8-12 hours (15 mg/kg)
  • Infuse over 60 minutes
  • Check trough before 4th dose
  • Target trough 10-15 mg/L

Adjust subsequent doses based on trough levels and clinical response, recognizing that individual pharmacokinetic variability necessitates personalized adjustments 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.